Mitochondria as a targeted delivery platform
Assigneecellvie Inc.
InventorsDedy SEPTIADI, Oleksandr LYTOVCHENKO, Nina DUMAUTHIOZ
Life of this patent
Estimating the term…
Loading patent…
Assigneecellvie Inc.
InventorsDedy SEPTIADI, Oleksandr LYTOVCHENKO, Nina DUMAUTHIOZ
Estimating the term…
The current invention focuses on ways to deliver various payloads including nucleic acids molecules (such as oligonucleotides), polypeptides (such as proteins), drugs or a combination thereof. As such, the invention relates to, inter alia, a mitochondrion comprising one or more payload(s) attached to the outer membrane of the mitochondrion, wherein the payload(s) is indirectly or directly electrostatically attached to the outer membrane of the mitochondrion. The invention further involves combining mitochondria comprising one or more payload(s) attached to the outer membrane of the mitochondrion with a protective layer that envelopes/encapsules and/or coats the mitochondrion and payload to provide a further delivery platform. This methodology is particularly effective for increasing the uptake and efficiency of the one or more payload(s) for therapeutic purposes.
-79. (canceled)
A mitochondrion comprising one or more payload(s) attached to the outer membrane of the mitochondrion, wherein the payload(s) is indirectly electrostatically attached to the outer membrane of the mitochondrion.
A method for attaching a payload to the outer membrane of a mitochondrion, the method comprising the steps of:
The method according to any of the previous method claims, wherein 50 μg to 200 μg of mitochondria are contacted with 0.1 to 50 μmol of payload and 0.2 to 10 μg of the protective layer.
Dependencies are inferred from the claim text.